Try our Advanced Search for more refined results

FTC Defends Impax Pay-For-Delay Ruling At 5th Circ.

By Bryan Koenig (December 11, 2019, 5:50 PM EST) -- The Federal Trade Commission has urged the Fifth Circuit to reject Impax Laboratories' appeal of an FTC order finding that the company's deal to delay its generic version of an opioid pain medication violated antitrust law, arguing that the agreement with Endo Pharmaceuticals "bears every hallmark" of the kind of pay-for-delay settlement the U.S. Supreme Court has deemed illegal....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!